Published in Neurosci Lett on March 04, 2015
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol (2016) 0.82
Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics (2016) 0.79
Functional Vascular Contributions to Cognitive Impairment and Dementia (VCID): Mechanisms and Consequences of Cerebral Microvascular Dysfunction in Aging. Am J Physiol Heart Circ Physiol (2016) 0.76
Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease. Psychiatry Investig (2015) 0.76
Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly. Front Aging Neurosci (2015) 0.76
Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide. Pflugers Arch (2016) 0.75
Sleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders. Sleep (2016) 0.75
Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease. BMC Med (2017) 0.75
White matter signal abnormalities in former National Football League players. Alzheimers Dement (Amst) (2017) 0.75
Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults. Neurobiol Aging (2017) 0.75
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 5.64
Cerebral autoregulation. Cerebrovasc Brain Metab Rev (1990) 5.13
Cerebral autoregulation dynamics in humans. Stroke (1989) 4.16
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol (2004) 3.56
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol (2011) 2.84
Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging (2000) 2.77
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation. Stroke (1995) 2.67
Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab (2008) 2.38
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci (1999) 2.21
Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res (2010) 2.04
Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke (2012) 1.99
Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol A Biol Sci Med Sci (2004) 1.92
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A (2007) 1.91
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Dynamic cerebral autoregulation during repeated squat-stand maneuvers. J Appl Physiol (1985) (2008) 1.39
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38
Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis (2002) 1.31
Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22
Transfer function analysis for clinical evaluation of dynamic cerebral autoregulation--a comparison between spontaneous and respiratory-induced oscillations. Physiol Meas (2003) 1.18
Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci (2002) 1.14
Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J Alzheimers Dis (2009) 1.10
Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging (2014) 1.08
Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J Cereb Blood Flow Metab (2013) 1.05
Cerebral autoregulation in Alzheimer's disease. J Cereb Blood Flow Metab (2011) 1.05
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep (2013) 1.02
Dynamic cerebral autoregulation: different signal processing methods without influence on results and reproducibility. Med Biol Eng Comput (2010) 0.99
Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol Aging (2008) 0.98
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci (2009) 0.92
Mechanisms underlying phase lag between systemic arterial blood pressure and cerebral blood flow velocity. Cerebrovasc Dis (2003) 0.90
Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. Stroke (2007) 0.88
Reliability, asymmetry, and age influence on dynamic cerebral autoregulation measured by spontaneous fluctuations of blood pressure and cerebral blood flow velocities in healthy individuals. J Neuroimaging (2013) 0.85
Autoregulation of cerebral blood flow to changes in arterial pressure in mild Alzheimer's disease. J Cereb Blood Flow Metab (2010) 0.84
Comparison of Non-invasive and Invasive Arterial Blood Pressure Measurement for Assessment of Dynamic Cerebral Autoregulation. Neurocrit Care (2014) 0.83
Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovasc Dis (2014) 0.82